Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Tanja Stocks

Tanja Stocks

Researcher

Tanja Stocks

Menstrual Factors, Reproductive History, Hormone Use, and Urothelial Carcinoma Risk : A Prospective Study in the EPIC Cohort

Author

  • Leila Lujan-Barroso
  • Edoardo Botteri
  • Saverio Caini
  • Börje Ljungberg
  • Nina Roswall
  • Anne Tjønneland
  • Bas Bueno-de-Mesquita
  • Inger T. Gram
  • Rosario Tumino
  • Lambertus A. Kiemeney
  • Fredrik Liedberg
  • Tanja Stocks
  • Marc J. Gunter
  • Neil Murphy
  • Iris Cervenka
  • Agnès Fournier
  • Marina Kvaskoff
  • Christel Häggström
  • Kim Overvad
  • Eiliv Lund
  • Marit Waaseth
  • Renée Turzanski Fortner
  • Tilman Kühn
  • Virginia Menéndez
  • Maria Jose Sánchez
  • Carmen Santiuste
  • Aurora Perez-Cornago
  • Raul Zamora-Ros
  • Amanda J. Cross
  • Antonia Trichopoulou
  • Anna Karakatsani
  • Eleni Peppa
  • Domenico Palli
  • Vittorio Krogh
  • Veronica Sciannameo
  • Amalia Mattiello
  • Salvatore Panico
  • Carla H. van Gils
  • N. Charlotte Onland-Moret
  • Aurelio Barricarte
  • Pilar Amiano
  • Kay Tee Khaw
  • Heiner Boeing
  • Elisabete Weiderpass
  • Eric J. Duell

Summary, in English

BACKGROUND: Urothelial carcinoma is the predominant (95%) bladder cancer subtype in industrialized nations. Animal and epidemiologic human studies suggest that hormonal factors may influence urothelial carcinoma risk. METHODS: We used an analytic cohort of 333,919 women from the European Prospective Investigation into Cancer and Nutrition Cohort. Associations between hormonal factors and incident urothelial carcinoma (overall and by tumor grade, tumor aggressiveness, and non-muscle-invasive urothelial carcinoma) risk were evaluated using Cox proportional hazards models. RESULTS: During a mean of 15 years of follow-up, 529 women developed urothelial carcinoma. In a model including number of full-term pregnancies (FTP), menopausal status, and menopausal hormone therapy (MHT), number of FTP was inversely associated with urothelial carcinoma risk (HR≥5vs1 = 0.48; 0.25-0.90; Ptrend in parous women = 0.010) and MHT use (compared with nonuse) was positively associated with urothelial carcinoma risk (HR = 1.27; 1.03-1.57), but no dose response by years of MHT use was observed. No modification of HRs by smoking status was observed. Finally, sensitivity analyses in never smokers showed similar HR patterns for the number of FTP, while no association between MHT use and urothelial carcinoma risk was observed. Association between MHT use and urothelial carcinoma risk remained significant only in current smokers. No heterogeneity of the risk estimations in the final model was observed by tumor aggressiveness or by tumor grade. A positive association between MTH use and non-muscle-invasive urothelial carcinoma risk was observed. CONCLUSIONS: Our results support that increasing the number of FTP may reduce urothelial carcinoma risk. IMPACT: More detailed studies on parity are needed to understand the possible effects of perinatal hormone changes in urothelial cells.

Department/s

  • LUCC: Lund University Cancer Centre
  • Urology - urothelial cancer, Malmö
  • Register-based epidemiology
  • EpiHealth: Epidemiology for Health

Publishing year

2020

Language

English

Pages

1654-1664

Publication/Series

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Volume

29

Issue

8

Document type

Journal article

Publisher

American Association for Cancer Research

Topic

  • Cancer and Oncology
  • Public Health, Global Health, Social Medicine and Epidemiology

Status

Published

Research group

  • Urology - urothelial cancer, Malmö
  • Register-based epidemiology

ISBN/ISSN/Other

  • ISSN: 1538-7755